Enterprise value to EBITDA forward of Parsons Corporation – HAM:59P
This article provides financial information for Parsons Corporation (HAM:59P) traded on the Hamburg Stock Exchange, focusing on its Enterprise Value to forward EBITDA. It appears to be a financial data page from TradingView, indicating no current trades and offering an overview of financials, news, community insights, and forecasts. The content primarily highlights data points related to the company's valuation metric, noting a period with value, change, and percentage change.
Sturm, Ruger & Company, Inc.(NYSE:RGR) dropped from Russell 3000E Growth Benchmark
Sturm, Ruger & Company, Inc. (NYSE:RGR) has been removed from the Russell 3000E Growth Benchmark. The firearms manufacturer designs, produces, and sells rifles, pistols, revolvers, and shotguns, along with accessories and parts. The company also has a castings segment for investment castings and metal injection molding parts.
Riot Platforms, Inc.(NasdaqCM: RIOT) added to Russell 3000E Growth Benchmark
Riot Platforms, Inc. (NasdaqCM: RIOT) has been included in the Russell 3000E Growth Benchmark. The announcement highlights the company's position as an integrated digital infrastructure entity with segments in Bitcoin Mining and Engineering, also focusing on AI/HPC uses. This inclusion in a significant growth index may draw more attention to Riot Platforms and its diverse operations within the digital infrastructure and cryptocurrency sectors.
Enterprise value to EBIT forward of Riot Platforms, Inc. – NASDAQ:RIOT
This article provides financial data for Riot Platforms, Inc. (NASDAQ: RIOT), focusing on its Enterprise Value to EBIT forward. It indicates the stock's market status as closed with no trades. The content is presented by TradingView, a platform offering various financial tools and market data services.
CLOV SEC Filings - Clover Health Investments Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors to access Clover Health Investments (CLOV) SEC filings, including annual reports (10-K), quarterly reports (10-Q), and material event reports (8-K). It details recent insider transaction activity, such as share withholdings for tax purposes and stock sales by executives. The platform also offers AI-powered summaries of these documents and tracks key company announcements, like the 2026 outlook presentation.
Enterprise value to revenue forward of Profusa, Inc. – NASDAQ:PFSA
This article focuses on the enterprise value to revenue forward metric for Profusa, Inc. (NASDAQ:PFSA). It is a financial data point presented by TradingView, a platform offering market insights and tools. The content provides a snapshot of this financial ratio for the company, accessible through their detailed financial sections.
Is Vaxcyte’s (PCVX) Russell Index Debut Quietly Reframing Its Long‑Term Governance And Growth Story?
Vaxcyte (PCVX) was recently added to several Russell growth indices and refreshed its board, with Moncef Slaoui joining as an independent director and Jacks Lee transitioning to a manufacturing consultant role. While these moves are positive for profile and governance, the primary investment narrative still hinges on upcoming Phase 3 data for VAX-31 and managing increasing cash burn before revenue generation. The article emphasizes that manufacturing execution is crucial for Vaxcyte's long-term success given its significant investment in U.S. capacity.
Price to sales forward of T-Mobile US, Inc. – NASDAQ:TMUS
This article provides financial data for T-Mobile US, Inc. (NASDAQ: TMUS), specifically focusing on its price to sales forward metric. It details where to find this financial information within the TradingView platform and lists various related services and tools offered by TradingView. The page appears to be a stub or a section of a larger financial data presentation for the company.
National Health Investors, Inc.(NYSE: NHI) dropped from Russell 3000 Growth Benchmark
National Health Investors, Inc. (NYSE: NHI) has been removed from the Russell 3000 Growth Benchmark. This news follows a series of recent analyst price target adjustments and an announcement that the company is set to join the S&P SmallCap 600 Index. NHI also recently reported its Q1 2026 earnings, posting increased normalized FFO and revenue, alongside a lowered full-year guidance and an announced dividend.
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports
The U.S. Justice Department has concluded its criminal investigation into Abbott Laboratories regarding the management of a baby formula facility where deadly bacteria were found. Instead of pursuing criminal charges, the DOJ has opted for civil penalties, according to a Wall Street Journal report. The probe concerned a facility suspected of causing infant deaths due to contamination.
